Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Effects of the Vaccin Against COVID 19 in a Cohort of Dialysis Patients: Adverse Events and Immunological Response"

NCT05055531 is registered in ClinicalTrials.gov with Raincy Montfermeil Hospital Group as lead sponsor.

NCT NCT05055531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Effects of the Vaccin Against COVID 19 in a Cohort of Dialysis Patients: Adverse Events and Immunological Response"
Lead sponsor
Raincy Montfermeil Hospital Group
Phase
Observational
Overall status
Unknown status
Start date
August 8, 2021
Completion date
June 30, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid epidemic